Literature DB >> 12086225

Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs.

Martin Knapp1, Daniel Chisholm, Morven Leese, Francesco Amaddeo, Michele Tansella, Aart Schene, Graham Thornicroft, Jose-Luis Vazquez-Barquero, Helle-Charlotte Knudsen, Thomas Becker.   

Abstract

OBJECTIVE: To compare service utilization and cost profiles of people with schizophrenia living in Europe in order to understand differences in treatment and care costs.
METHOD: Cross-sectional samples were taken of people with schizophrenia in five European locations. Sociodemographic, clinical and service use data were collected via interviewer-administered questionnaires. Site-specific unit costs were obtained, transformed subsequently into a single currency (UK pound). Multiple regression analyses were conducted.
RESULTS: There were widespread and considerable differences between sites in service utilization patterns and associated costs. Higher needs, greater symptom severity and longer psychiatric history are associated with higher costs: quality of life and service satisfaction are not. Few differences were found between sites in patterns of association with cost.
CONCLUSION: Comparative analyses of the use and cost of mental health services can highlight existing variations helpfully in service provision and uptake. Methodological consistency is required if meaningful conclusions are to be drawn from such comparative data.

Entities:  

Mesh:

Year:  2002        PMID: 12086225     DOI: 10.1034/j.1600-0447.2002._10310.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  36 in total

1.  The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study.

Authors:  Paul E Bebbington; Matthias Angermeyer; Jean-Michel Azorin; Traolach Brugha; Reinhold Kilian; Sonia Johnson; Mondher Toumi; Asa Kornfeld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-09       Impact factor: 4.328

2.  Patterns of mental health service utilisation in Italy and Spain--an investigation using the European Service Mapping Schedule.

Authors:  Luis Salvador-Carulla; Giuseppe Tibaldi; Sonia Johnson; Elena Scala; Cristina Romero; Carmine Munizza
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-02       Impact factor: 4.328

3.  Does additional care provided by a consumer self-help group improve psychiatric outcome? A study in an Italian community-based psychiatric service.

Authors:  Lorenzo Burti; Francesco Amaddeo; Marta Ambrosi; Chiara Bonetto; Doriana Cristofalo; Mirella Ruggeri; Michele Tansella
Journal:  Community Ment Health J       Date:  2005-12

4.  The Camberwell assessment of need as an outcome measure in routine mental health care.

Authors:  Erik Wennström; Frits-Axel Wiesel
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-06-14       Impact factor: 4.328

Review 5.  Pharmacoeconomics of long-acting risperidone: results and validity of cost-effectiveness models.

Authors:  Alan Haycox
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 6.  [Early recognition and intervention for schizophrenia].

Authors:  N Mossaheb; G Wiesegger; G P Amminger; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2006-01       Impact factor: 1.214

7.  The EPSILON Study - a study of care for people with schizophrenia in five European centres.

Authors:  Thomas Becker; Martin Knapp; Helle C Knudsen; Aart Schene; Michele Tansella; Graham Thornicroft; José L Vázquez-Barquero
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

8.  Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach.

Authors:  Annemieke De Ridder; Diana De Graeve
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  [Guideline conformity and outcome of inpatient treatment for schizophrenia. A clinical comparison].

Authors:  B Janssen; S Weinmann; M Berger; M Härter; T Held; M Leipert; H J Luderer; M Schwarz; T Steinert; W Gaebel
Journal:  Nervenarzt       Date:  2005-03       Impact factor: 1.214

Review 10.  Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective.

Authors:  Mauro Percudani; Corrado Barbui; Michele Tansella
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.